Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase II study investigates Tarceva in poor performance NSCLC patients

March 23, 2004

Chiron discontinues development of tezacitabine

March 23, 2004

Pharmacia describes new protein kinase inhibitors, their preparation and use

March 22, 2004

GTx enters collaboration and license agreement with Ortho Biotech for andarine

March 22, 2004

Greater prevention of breast cancer recurrence with exemestane

March 22, 2004

Recombinant immunotoxins against breast cancer, osteosarcoma and neuroblastoma

March 22, 2004

Corgenix Medical and Genesis Bioventures sign merger agreement

March 19, 2004

Maxim reacquires rights to MX-2105 series

March 19, 2004

Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim

March 19, 2004

Launch of new Salagen dosage

March 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...